(Q71023395)
Statements
Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease (English)
E F Reed
B Hong
E Ho
P E Harris
J Weinberger
1 February 1996